New dual dye for vitreoretinal surgery with increased transparency.

Area of Science:

• Ophthalmology
• Surgical Innovation
• Biomaterials Science

Background:

• Vitreoretinal surgery requires specialized dyes for visualizing delicate tissues.
• Existing dyes like Brilliant Blue G (BBG) have limitations in transparency and handling.
• There is a need for improved dye formulations that enhance intraoperative visualization and safety.

Purpose of the Study:

• To develop a novel dye formulation for vitreoretinal surgery with enhanced transparency and handling properties.
• To synthesize and evaluate a new blue dye (DDG) and a novel additive (diglycerol).
• To assess the safety profile and staining efficacy of the new dye formulation.

Main Methods:

• Synthesis of a new blue dye, DDG.
• Evaluation of diglycerol as a density-increasing additive, assessing its toxicity and impact on trypan blue (TB) staining.
• Determination of dye solution transparency and viscosity.
• Testing on a collagen membrane model for epiretinal membrane staining.

Main Results:

• DDG demonstrated good staining properties and a favorable safety profile, serving as an alternative to BBG.
• Diglycerol, a non-toxic additive, replaced PEG3350, reducing viscosity without compromising staining.
• A 40% reduction in TB concentration was achieved while maintaining equivalent staining levels.
• The new formulation exhibited greater transparency and reduced viscosity, facilitating surgical removal.

Conclusions:

• A new dye preparation was developed with superior performance compared to existing BBG and TB combinations.
• The formulation's reduced TB concentration and viscosity, coupled with maintained density, enhance surgical tolerance and handling.
• This innovation promises improved safety and efficacy in vitreoretinal surgical procedures.